IA
PETX

IFP Advisors’s Aratana Therapeutics, Inc. PETX Stock Holding History

IFP Advisors’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-600
Closed -$4K – 3849
2018
Q4 		$4K Hold
600
– – ﹤0.01% 2998
2018
Q3 		$4K Hold
600
– – ﹤0.01% 3359
2018
Q2 		$3K Hold
600
– – ﹤0.01% 3540
2018
Q1 		$3K Hold
600
– – ﹤0.01% 3454
2017
Q4 		$3K Hold
600
– – ﹤0.01% 3505
2017
Q3 		$4K Hold
600
– – ﹤0.01% 3570
2017
Q2 		$4K Hold
600
– – ﹤0.01% 3565
2017
Q1 		$3K Hold
600
– – ﹤0.01% 3593
2016
Q4 		$4K Hold
600
– – ﹤0.01% 3452
2016
Q3 		$6K Sell
600
-50
-8% -$415 ﹤0.01% 3178
2016
Q2 		$4K Buy
+650
New +$4.18K ﹤0.01% 3298

Other funds holding PETX

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

IFP Advisors's PETX Position: Q1 2019 in Review

IFP Advisors sold out of Aratana Therapeutics, Inc. (PETX) in Q1 2019, closing a stake of 600 shares — an estimated $4K sold.

IFP Advisors first reported a position in PETX in Q2 2016 and held it in 11 quarters. The position peaked at $6K in Q3 2016. 104 funds tracked by Wall St. Rank hold PETX as of Q1 2019.

  • IFP Advisors reported no remaining Aratana Therapeutics, Inc. position as of Q1 2019 after selling out during the quarter.
  • IFP Advisors sold 600 Aratana Therapeutics, Inc. shares in Q1 2019, an estimated $4K.
  • IFP Advisors first reported a position in Aratana Therapeutics, Inc. in Q2 2016 and held it in 11 quarters.
  • IFP Advisors's Aratana Therapeutics, Inc. position peaked at $6K in Q3 2016.
  • 104 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q1 2019.

Based on IFP Advisors's 13F filing for Q1 2019, filed 15 May 2019.